Your end-to-end partner,

From biomarker discovery to IVD kit production.

Trusted by biopharmaceutical organizations, researchers and healthcare professionals for providing a powerful multi-omics approach across the entire drug and diagnostic product development pipelines, with precision and regulatory expertise.

Our DNA

At the core of our values lies a commitment to fostering collaboration and crafting tailored innovative solutions for academia, research organizations, and biopharmaceutical companies, recognizing the unique challenges and opportunities each sector presents.

Unique solutions

Swift turnaround times

Steadfast collaboration

Cost-effectiveness

Regulatory compliance

Innovative technology

Global presence

Client-centric approach

Our services

From state-of-the-art genomics and proteomics solutions to Mass Spectrometry assays, data science and ASD/Production, our cutting-edge services are all designed to accelerate your research and biomarker discovery journey.

Bioanalytical Services

Biobanking

Genomics

Proteomics

Lipido-metabolomics

Associated Services

Bioinformatics & Biostatistics

Assay Development & IVD kit Production

Support throughout the whole process

An essential step in drug development

FMP plays a pivotal role in drug development’s discovery phase, leveraging advanced expertise and cutting-edge technologies to craft customized bioanalytical strategies for discovery programs.

Leveraging a holistic multi-omic approach, we delve deep into biomarker/target discovery and validation, laying the foundation for robust disease understanding.

Our expertise extends to elucidating the intricate mechanisms of action underlying various diseases, empowering pharmaceutical and biotechnology companies throughout this critical phase.

Laying the foundation - Investigating safety and efficacy before human trials

In pre-clinical research, we offer comprehensive services from early to late stages.

Our expertise includes biomarker studies, drug safety and efficacy assessments, drug concentration quantification, and custom assay development, providing tailored solutions for advancing biomedical science.

Leveraging both in vitro and in vivo experiments, we rigorously evaluate the effects of drugs to ensure thorough understanding and informed decision-making throughout the drug development process.

Comprehensive support across trial phases

In clinical development, our support spans phases 1 to 3, encompassing a wide array of services. We investigate short-term adverse reactions, evaluate drug activity, measure efficacy, and discover prognostic and diagnostic biomarkers. We also initiate CDx development, evaluate drug effects and adverse events, and validate drug response signatures and biomarkers clinically. Furthermore, we conduct CDx CoU validation and develop custom assays, ensuring comprehensive assistance throughout the clinical trial journey.

Steadfast support for post-market surveillance

In the post-approval phase, we remain steadfast in our commitment to ensuring the ongoing safety and efficacy of approved treatments.

Our comprehensive post-market surveillance program includes diligent monitoring of long-term biomarker efficacy, safety profiles, and the balance of risks and benefits associated with the use of pharmaceutical products. Leveraging advanced technologies and methodologies, we conduct thorough assessments to identify any emerging concerns and promptly address them to safeguard patient well-being. Additionally, we undertake the production of CDx kits, facilitating the integration of personalized medicine approaches into clinical practice and enhancing patient care outcomes.